Bloodline

Home
About
Call for Papers
Free Membership
Search


Educational Features

Image Atlas
Case Studies
Private Lectures
Conference Reviews
Journal Articles
Book Reviews
Glossary


Resources

Conference Calendar
Grants & Fellowships
Hematology Links
BMT Reviews
Classifieds


Specialties

BMT/Stem Cell
Cord Blood
Thrombosis
Hemostasis
Laboratory
Malignancies
Pediatrics
Red Cell Disorders
Infections
Transfusion Medicine
Veterinary


News

Hematology News
BloodLink Newsletter
Blood News Update


Discussion

Today's Discussion
Create New Topic
List by Topic

Members

Join Now
Login

websel.gif:

toprated.gif:

A Lupus patient clots

Patient I.A..- 49 y/o wf with SLE x 14 years S/P aorto-femoral bypass 3 weeks ago presents with postural hypotension. Dopplers of legs negative but Spiral CT shows saddle-distribution embolus. History of DVT 6 years ago after left THR.

What tests should be drawn? Ultimately what should target INR be? How long should she be on Coumadin?

Naturally with her history of lupus, a work-up for Anti-Phospholipid Antibody Syndrome (APAS) is first and foremost-Lupus anti-coagulant screen and IgG and IgM anti-cardiolipins (ACLA) were negative, as was the seemingly more sensitive IgA ACLA and anti-beta-glycoprotein I. A RAPC assay, PCR for PT 20,210, Protein C,S and ATIII levels were all negative- they were ordered because of history of clotting at age < 45. The target INR is historically 3.0-4.0 in APAS patients but we advocate 3.0-3.5 and then check a chromogenic Factor X assay and raise the Coumadin dose to INR of 4.0 if the FX level is still > 30%. If the hypercoaguable work-up is completely negative, one could argue for just 6-12 months of Coumadin given presumed risk factor of recent surgery as was the case 6 years ago with the first DVT though her recent arterial clot is suspicious for APAS but on the otherhand she is also a diabetic and hypertensive at risk for arterial disease.


sm_cjpLogo.gifCopyright 1995-2010 - Carden Jennings Publishing Co., Ltd. All rights reserved. The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Carden Jennings Publishing Co., Ltd., assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.

Related Content